Results 181 to 190 of about 382,920 (355)

Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma. [PDF]

Immunotargets Ther
Liu S, Wu J, Liu J, Wu K, Huang Y, Geng S, Wang Y, Weng J, Du X, Lai P.   +9 more
europepmc   +1 more source

LACK OF REVERSAL WITH VERAPAMIL OF DRUG RESISTANCE IN MULTIPLE MYELOMA [PDF]

, 1990
Brian G.M. Durie
openalex   +1 more source

Early‐Life Exposures and Risk of Multiple Myeloma: A Population‐Based Case–Control Study in Australia

International Journal of Cancer, EarlyView.
Early‐life exposures may influence immune system development and, in turn, affect cancer susceptibility. In this population‐based case‐control study, the authors examined whether in utero or early childhood exposures were associated with the risk of developing multiple myeloma in adulthood.
Zhuoyu Sun, Julie K. Bassett, Simon Cheah, Fiona J. Bruinsma, Wendy Cozen, Simon J. Harrison, H. Miles Prince, Nicole Wong Doo, Graham G. Giles, Roger L. Milne, Brigid M. Lynch   +10 more
wiley   +1 more source

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

, 1996
M. Attal, J. Harousseau, A. Stoppa, J. Sotto, J. Fuzibet, J. Rossi, P. Casassus, H. Maisonneuve, T. Facon, N. Ifrah, C. Payen, R. Bataille   +11 more
semanticscholar   +1 more source

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.

New England Journal of Medicine, 2016
A. Palumbo, A. Chanan-Khan, K. Weisel, A. Nooka, T. Masszi, M. Beksaç, I. Špička, V. Hungria, M. Munder, M. Mateos, T. Mark, M. Qi, J. Schecter, H. Amin, X. Qin, W. Deraedt, T. Ahmadi, A. Spencer, P. Sonneveld   +18 more
semanticscholar   +1 more source

Obesity Accelerates Multiple Myeloma Progression in Certain Mouse Models and in Humans. [PDF]

Cancer Prev Res (Phila)
Fairfield H, Marinac CR, Hamidi H, Knox K, Nestor B, Marques-Mourlet C, Diaz G, Wong CV, Mishra AK, Schimelman A, Qiang YW, Karam M, Farrell M, Jachimowicz E, Stohn JP, Birmann BM, Cornelius P, Reagan MR.   +17 more
europepmc   +1 more source

Study: Stem cell transplant should remain preferred therapy for multiple myeloma [PDF]

, 2016
Carrie Printz
openalex   +1 more source

Post‐Translational Modifications of Key Proteins in Hematologic Malignancies: Carcinogenic Mechanisms, Biomarker Potential, and New Therapeutic Strategies

iLABMED, EarlyView.
This article reviews the pivotal role of post‐translational modifications of proteins in the development and progression of hematologic malignancies, and explores their clinical translation potential as novel biomarkers and therapeutic targets. ABSTRACT Post‐translational modifications (PTMs) of proteins have emerged as critical regulators in the ...
Yuxuan Han, Chaowei Zhang, Weiyi Yao, Qing Hong, Xinyu Tang, Yanan Zhu, Na Chen   +6 more
wiley   +1 more source

Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France. [PDF]

Clin Hematol Int
Olivier D, Garlantezec R, Perrot A, Macro M, Royer B, Belhadj Merzoug K, Vincent L, Chalopin T, Frenzel L, Bobin A, Mohty M, Touzeau C, Zunic P, LE Calloch R, Lachenal F, Roussel M, Richez-Olivier V, Fleury J, Loppinet E, Leduc I, Tiab M, Delaunay J, Gutnecht J, Corm S, Bazin F, McKelvie-Sebileau P, Rollet S, Mouton H, Gibel L, Louni C, Boumendile A, Hulin C.   +31 more
europepmc   +1 more source

Genotoxicity and functionality assessment of a bone marrow stromal cell line following chemotherapy exposure in an in vitro model of multiple myeloma [PDF]

, 2017
Simon William Andrews
openalex